INTRODUCTION: Although recurrent venous thromboembolism is a known risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), the prevalence of CTEPH after recurrent pulmonary embolism (PE) is not clear. MATERIALS AND METHODS: A cohort screening study was performed to clarify the prevalence of echocardiographic variables indicating pulmonary hypertension (PH) in patients after recurrent PE. RESULTS: 43 survivors of recurrent PE could be enrolled. Echocardiography indicated likely PH in 7 patients. In 5 out of these 7 patients PH was likely and the left ventricular function was normal. Right heart catheterization and ventilation/perfusion lung scan were performed in these patients. CTEPH could be diagnosed in all 5 patients (11.6% of the total study population). No World Health Organisation functional class (WHO-FC) I patient was suspected to have CTEPH. CTEPH was significantly more often diagnosed in WHO-FC III than in WHO-FC II (33.3% versus 9.5%; p=0.024). CONCLUSIONS: CTEPH was found to be a frequent sequela in patients with recurrent PE. The prevalence of CTEPH is dependent on the patient's functional class. Evaluation for PH might be useful in symptomatic patients after recurrent PE.
INTRODUCTION: Although recurrent venous thromboembolism is a known risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), the prevalence of CTEPH after recurrent pulmonary embolism (PE) is not clear. MATERIALS AND METHODS: A cohort screening study was performed to clarify the prevalence of echocardiographic variables indicating pulmonary hypertension (PH) in patients after recurrent PE. RESULTS: 43 survivors of recurrent PE could be enrolled. Echocardiography indicated likely PH in 7 patients. In 5 out of these 7 patients PH was likely and the left ventricular function was normal. Right heart catheterization and ventilation/perfusion lung scan were performed in these patients. CTEPH could be diagnosed in all 5 patients (11.6% of the total study population). No World Health Organisation functional class (WHO-FC) I patient was suspected to have CTEPH. CTEPH was significantly more often diagnosed in WHO-FC III than in WHO-FC II (33.3% versus 9.5%; p=0.024). CONCLUSIONS:CTEPH was found to be a frequent sequela in patients with recurrent PE. The prevalence of CTEPH is dependent on the patient's functional class. Evaluation for PH might be useful in symptomatic patients after recurrent PE.
Authors: F C Roller; S Kriechbaum; A Breithecker; C Liebetrau; M Haas; C Schneider; A Rolf; S Guth; E Mayer; C Hamm; G A Krombach; C B Wiedenroth Journal: Eur Radiol Date: 2018-08-29 Impact factor: 5.315
Authors: Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach Journal: Eur Radiol Date: 2016-09-20 Impact factor: 5.315
Authors: Beatrice A Golomb; Virginia T Chan; Julie O Denenberg; Sabrina Koperski; Michael H Criqui Journal: BMJ Open Date: 2014-03-21 Impact factor: 2.692
Authors: Nick H Kim; Marion Delcroix; Xavier Jais; Michael M Madani; Hiromi Matsubara; Eckhard Mayer; Takeshi Ogo; Victor F Tapson; Hossein-Ardeschir Ghofrani; David P Jenkins Journal: Eur Respir J Date: 2019-01-24 Impact factor: 16.671